All articles
Articleskin agingGHK-Curetinoids

The skin-aging stack with actual evidence

What the skin-aging interventions with real evidence look like — retinoids, sunscreen, GHK-Cu, and where peptides genuinely fit. No miracle cure framing.

May 7, 2026 · 6 min read · By Strength Peptide Editors


The skin-aging stack with actual evidence is shorter than the marketing-driven version. Most of what works has been known for decades and most of what is new is incremental. Where peptides fit — specifically GHK-Cu — is real but bounded. This post walks through the interventions that have genuine evidence behind them, where GHK-Cu sits in that hierarchy, and the claims to be skeptical of when reading skincare marketing.

What actually drives visible skin aging

Skin aging is driven by two largely separable processes:

  • Intrinsic aging — chronological aging of skin tissue, mostly genetic, slow, inevitable
  • Extrinsic aging — environmental damage, primarily UV exposure, with smoking, pollution, and chronic inflammation as secondary contributors

Extrinsic aging — particularly photoaging — accounts for the majority of what people see in the mirror as "aged skin." Wrinkles, pigmentation, loss of elasticity, and dullness in sun-exposed areas are largely UV-driven. Compare the underside of a forearm to its top side at age 60 and the difference is almost entirely photoaging.

This matters for the intervention hierarchy. The single most important anti-aging skincare decision is sun protection, by a large margin. Everything else is secondary.

The evidence-based hierarchy

Ranked roughly by effect size for visible skin-aging outcomes:

TierInterventionWhat the evidence supports
1Daily broad-spectrum sunscreenSlows photoaging; prevents ongoing damage
1Smoking cessationReverses some smoking-related skin aging
2Topical retinoids (tretinoin, retinol)Increases collagen, reduces fine lines, improves pigmentation
2Vitamin C (L-ascorbic acid)Antioxidant, brightening, collagen support
3Alpha hydroxy acidsSurface texture and tone
3NiacinamideBarrier function, modest pigmentation effect
4GHK-CuCollagen, elastin, wound healing — peptide-class evidence
4Growth factor topicalsMixed evidence, varies by product
5Most cosmetic peptidesMarketing tier — limited demonstrated effect

Tier 1 is the foundation. Tier 2 is where the bulk of cosmetic improvement comes from. Tier 3 and 4 are real but additive. Tier 5 is mostly marketing.

What GHK-Cu actually does

GHK-Cu is a tripeptide — glycyl-histidyl-lysine — bound to copper. It occurs naturally in human plasma, where its concentration declines from peak levels in the 20s to roughly a third of that by age 60.

The proposed mechanisms for skin:

  • Stimulates collagen and elastin production in fibroblasts
  • Promotes wound healing
  • Has antioxidant effects
  • Modulates expression of skin remodeling genes
  • Improves dermal thickness in some studies

The evidence base for GHK-Cu in skin is meaningfully better than for most "peptide" cosmetic ingredients. There are clinical studies showing improvement in fine lines, skin firmness, and dermal density with topical formulations. The effect size is modest — not retinoid-class — but it is real and the mechanism is coherent.

For deeper detail, see GHK-Cu for skin and GHK-Cu research evidence.

Topical vs injection — the honest comparison

GHK-Cu is used both as a topical and as a low-dose subcutaneous injection. The communities have different framings:

RouteProsCons
TopicalTargeted to skin; well-tolerated; bulk of cosmetic evidencePenetration limited by skin barrier
SubcutaneousSystemic availability; potentially more biologic effectLess skin-targeted; injection logistics
With microneedlingImproved penetration of topicalProcedural complexity; technique-dependent

The bulk of the cosmetic skin evidence is for topical formulations, often combined with delivery enhancement. The subcutaneous route has stronger reasoning for systemic indications (wound healing, hair follicle support) than for facial skin specifically.

For the comparison, see GHK-Cu topical vs injection and GHK-Cu with microneedling.

Where GHK-Cu fits in a real stack

A reasonable evidence-based skin-aging stack:

  1. Daily broad-spectrum sunscreen, SPF 30 or higher
  2. Topical retinoid at night — tretinoin if you can get it, retinol if not
  3. Topical vitamin C in the morning under sunscreen
  4. Optional: GHK-Cu serum as an add-on, particularly if retinoid intolerance limits other options
  5. Optional: barrier-supporting moisturizer with niacinamide
  6. Optional: in-office treatments (microneedling, certain lasers) at intervals

GHK-Cu fits as a tier-2 add-on, not as the foundation. Putting GHK-Cu on poorly-protected, untreated skin and expecting cosmetic transformation is a common pattern that disappoints people. Putting GHK-Cu on top of sunscreen-and-retinoid as an additional input — the marginal benefit is plausibly real.

For comparison with retinoids, see GHK-Cu vs retinol.

The hair follicle question

GHK-Cu has research supporting hair follicle stimulation — increased follicle size, anagen phase signaling, and reduced 5-alpha-reductase activity in some studies. This is a separate use case from facial skin and the evidence varies in quality. Topical GHK-Cu for hair is reported anecdotally in significant volumes; the clinical evidence is thinner than for skin.

See GHK-Cu for hair growth for the deeper coverage.

Cosmetic peptides that are mostly marketing

The cosmetic skincare industry has produced a long list of peptides marketed for skin aging. Many of these have little independent clinical evidence. Examples that get heavy marketing without strong supporting data include various oligopeptides, palmitoyl pentapeptide variants, and matrixyl-derivative combinations sold at premium prices.

Some of these may have modest effects. Few have effects comparable to a tier-1 or tier-2 intervention. Buying a $150 peptide serum while skipping sunscreen is a bad trade.

How to read peptide skincare claims:

  • Is there clinical evidence in humans, not just in vitro fibroblast studies?
  • Is the effect size meaningful or just statistically significant?
  • Is the formulation actually delivering the peptide through the skin barrier?
  • Is the comparison to a real control or to vehicle alone?

For most cosmetic peptides, the answers are some combination of "no," "small," "unclear," and "vehicle alone."

Internal vs external — the lifestyle inputs

The skin-aging stack is not purely topical:

  • Sleep — direct effects on skin repair processes
  • Diet — chronic glycation accelerates collagen damage
  • Hydration — modest effect, but real
  • Smoking — large negative effect; cessation reverses some of it
  • Alcohol — chronic heavy use accelerates skin aging
  • Stress — cortisol effects on collagen turnover

These are not peptide questions but they are skin-aging questions, and they often matter more than the topical you choose. A smoker on tretinoin will have worse skin aging than a non-smoker on plain moisturizer.

What this looks like in practice

For someone in their 30s, 40s, or 50s wanting to slow skin aging:

  1. Sunscreen daily, year-round, on face and exposed skin
  2. A retinoid 3–7 nights per week, building tolerance gradually
  3. Vitamin C in the morning if budget allows
  4. GHK-Cu as a serum if you want a peptide layer with reasonable evidence
  5. In-office procedures at appropriate intervals if motivated
  6. Address sleep, smoking, alcohol, and diet patterns
  7. Reasonable expectations: visible improvement is gradual, modest, and additive

Skin aging is one of the more peptide-relevant areas — GHK-Cu has better evidence than most cosmetic peptides — but it is not transformed by peptides alone. The boring foundation does the heavy lifting. GHK-Cu is a defensible add-on, not the headline.

Free weekly newsletter

Get the strength peptide highlights, weekly.

One short email a week — new guides, study readouts, supply updates, and dosing tips. Plain-English, no spam.

Unsubscribe anytime. We never share your email.